Literature DB >> 33665015

The long non-coding RNA MEG3 plays critical roles in the pathogenesis of cholesterol gallstone.

Changlin Qian1,2, Weiqing Qiu2, Jie Zhang2, Zhiyong Shen2, Hua Liu2, Yongjie Zhang1.   

Abstract

BACKGROUND: Cholesterol gallstone (CG) is the most common gallstone disease, which is induced by biliary cholesterol supersaturation. The purpose of this study is to investigate the pathogenesis of CG.
METHODS: Sixteen mice were equally and randomly divided into model group and normal control group. The model group was fed with lithogenic diets to induce CG, and then gallbladder bile lipid analysis was performed. After RNA-seq library was constructed, differentially expressed mRNAs (DE-mRNAs) and differentially expressed lncRNAs (DE-lncRNAs) between model group and normal control group were analyzed by DESeq2 package. Using the cluster Profiler package, enrichment analysis for the DE-mRNAs was carried out. Based on Cytoscape software, the protein-protein interaction (PPI) network and competing endogenous RNA (ceRNA) network were built. Using quantitative real-time reverse transcription-PCR (qRT-PCR) analysis, the key RNAs were validated.
RESULTS: The mouse model of CG was suc cessfully established, and then 181 DE-mRNAs and 33 DE-lncRNAs between model and normal groups were obtained. Moreover, KDM4A was selected as a hub node in the PPI network, and lncRNA MEG3 was considered as a key lncRNA in the regulatory network. Additionally, the miR-107-5p/miR-149-3p/miR-346-3-MEG3 regulatory pairs and MEG3-PABPC4/CEP131/NUMB1 co-expression pairs existed in the regulatory network. The qRT-PCR analysis showed that KDM4A expression was increased, and the expressions of MEG3, PABPC4, CEP131, and NUMB1 were downregulated.
CONCLUSION: These RNAs might be related to the pathogenesis of CG. ©2021 Qian et al.

Entities:  

Keywords:  Animal modeling; Cholesterol gallstone; Competing endogenous RNA; Differential expression analysis; Enrichment analysis; Library construction

Year:  2021        PMID: 33665015      PMCID: PMC7908887          DOI: 10.7717/peerj.10803

Source DB:  PubMed          Journal:  PeerJ        ISSN: 2167-8359            Impact factor:   2.984


  40 in total

1.  Claudin-3 regulates bile canalicular paracellular barrier and cholesterol gallstone core formation in mice.

Authors:  Hiroo Tanaka; Mitsunobu Imasato; Yuji Yamazaki; Kengo Matsumoto; Koshi Kunimoto; Julien Delpierre; Kirstin Meyer; Marino Zerial; Naho Kitamura; Mitsuhiro Watanabe; Atsushi Tamura; Sachiko Tsukita
Journal:  J Hepatol       Date:  2018-09-11       Impact factor: 25.083

Review 2.  Correlation Coefficients: Appropriate Use and Interpretation.

Authors:  Patrick Schober; Christa Boer; Lothar A Schwarte
Journal:  Anesth Analg       Date:  2018-05       Impact factor: 5.108

Review 3.  An update on the pathogenesis of cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q-H Wang; Piero Portincasa
Journal:  Curr Opin Gastroenterol       Date:  2018-03       Impact factor: 3.287

4.  Regulation of cholesterol and bile acid homeostasis by the cholesterol 7α-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice.

Authors:  Tiangang Li; Jessica M Francl; Shannon Boehme; John Y L Chiang
Journal:  Hepatology       Date:  2013-07-31       Impact factor: 17.425

5.  Brahma related gene 1 (Brg1) contributes to liver regeneration by epigenetically activating the Wnt/β-catenin pathway in mice.

Authors:  Nan Li; Ming Kong; Sheng Zeng; Chenzhi Hao; Min Li; Luyang Li; Zheng Xu; Min Zhu; Yong Xu
Journal:  FASEB J       Date:  2018-07-12       Impact factor: 5.191

6.  Evidence of differential allelic effects between adolescents and adults for plasma high-density lipoprotein.

Authors:  Rita P S Middelberg; Andrew C Heath; Pamela A F Madden; Grant W Montgomery; Nicholas G Martin; John B Whitfield
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

7.  MiR-149 Compromises the Reactions of Liver Cells to Fatty Acid via its Polymorphism and Increases Non-Alcoholic Fatty Liver Disease (NAFLD) Risk by Targeting Methylene Tetrahydrofolate Reductase (MTHFR).

Authors:  Xianchao An; Zonglin Yang; Zhengzhuang An
Journal:  Med Sci Monit       Date:  2017-05-16

8.  FQC Dashboard: integrates FastQC results into a web-based, interactive, and extensible FASTQ quality control tool.

Authors:  Joseph Brown; Meg Pirrung; Lee Ann McCue
Journal:  Bioinformatics       Date:  2017-06-09       Impact factor: 6.937

9.  Plant-Based Diet, Cholesterol, and Risk of Gallstone Disease: A Prospective Study.

Authors:  Chun-Ming Chang; Tina H T Chiu; Chia-Chen Chang; Ming-Nan Lin; Chin-Lon Lin
Journal:  Nutrients       Date:  2019-02-04       Impact factor: 5.717

10.  miR-149 controls non-alcoholic fatty liver by targeting FGF-21.

Authors:  Junjie Xiao; Dongchao Lv; Yingying Zhao; Xiaoyu Chen; Meiyi Song; Jingqi Liu; Yihua Bei; Fei Wang; Wenzhuo Yang; Changqing Yang
Journal:  J Cell Mol Med       Date:  2016-04-06       Impact factor: 5.310

View more
  1 in total

Review 1.  Research progress of nanocarriers for gene therapy targeting abnormal glucose and lipid metabolism in tumors.

Authors:  Xianhu Zeng; Zhipeng Li; Chunrong Zhu; Lisa Xu; Yong Sun; Shangcong Han
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.